Santen Pharmaceutical Announces the Conclusion of the Agreement on Co-Promotion of VEGF Trap-Eye (Aflibercept Intravitreal Injection)
May 08, 2012 03:35 ET
|
Santen Pharmaceutical Co., Ltd.
OSAKA, Japan, May 8, 2012 (GLOBE NEWSWIRE) -- Santen Pharmaceutical Co., Ltd. (Head office: Osaka, hereafter referred to as "Santen") announced today that Santen and Bayer Yakuhin, Ltd. (Head office:...